Kuen‐Feng Chen

Biochemistry, Genetics and Molecular Biology · Life Sciences

46h-index5.9kcitations173works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Tyrosine Phosphatases(46), Cancer-related Molecular Pathways(35), Cytokine Signaling Pathways and Interactions(34), Cancer Mechanisms and Therapy(27), PI3K/AKT/mTOR signaling in cancer(26)

Publications163 total

Data from Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
2023Open Access
Data from Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
2023Open Access
Supplementary Figures 1-3, Table 1 from Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
2023Open Access
Supplementary Figures 1-3, Table 1 from Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
2023Open Access
TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1
Cancer Letters·2020· 24 cited
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation
Cell Death and Disease·2019· 89 citedOpen Access
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response
European Journal of Cancer·2018· 75 cited
Abstract 4372: SET/PP2A/SHP-1/Lyn oncogenic signaling contributes to tumor aggressiveness in diffuse large B cell lymphoma
Cancer Research·2018
Abstract 762: Disrupting the glucose-influx induced β-catenin activation for the treatment of hepatocellular carcinoma
Cancer Research·2018
Antagonizing SET Augments the Effects of Radiation Therapy in Hepatocellular Carcinoma through Reactivation of PP2A-Mediated Akt Downregulation
Journal of Pharmacology and Experimental Therapeutics·2018· 11 citedOpen Access
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
Liver International·2018· 11 cited
Corrigendum to “Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation” [Lung Cancer 112 (October) (2017) 81–89]
Lung Cancer·2018· 1 citedOpen Access
Corrigendum to “Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation” [Lung Cancer 112, (October) (2017) 81–89]
Lung Cancer·2018· 2 cited
Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” [Eur. J. Med. Chem. 55 (2012) 220–227]
European Journal of Medicinal Chemistry·2017· 1 cited
SHP-1 agonist SC-43 enhanced the anti-tumor effect of docetaxel through suppressing p-STAT3 in triple negative breast cancer cells
Annals of Oncology·2017Open Access
Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation
Lung Cancer·2017· 23 cited
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells
Experimental & Molecular Medicine·2017· 39 citedOpen Access
Erratum: SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma
Oncogene·2017· 5 cited
Abstract 2087: Pan-HER inhibitor, varlitinib, disrupts HER/ERK signaling and causes apoptosis in triple-negative breast cancer cells
Cancer Research·2017· 1 cited
Abstract 4201: Combination of palbociclib with enzalutamide shows <i>in vitro</i> activity in RB-proficient and androgen receptor-positive triple-negative breast cancer cells
Cancer Research·2017· 1 cited
page 1 of 9Next →

Frequent Co-authors

Chung-Wai Shiau(22), Chun‐Yu Liu(21), Wei‐Tien Tai(19), Ann‐Lii Cheng(19), Pei‐Jer Chen(14), Pei‐Yi Chu(13), Man‐Hsin Hung(9), Jui-Wen Huang(7), Chung‐Wai Shiau(6), Hsiang–Po Huang(5), Ling‐Ming Tseng(5), Jung-Chen Su(5), Ching-Shih Chen(4), Chen‐Si Lin(4), Hao‐Wei Teng(4), Li‐Ju Chen(4), Feng‐Shu Hsieh(4), Yao‐Li Chen(4), Hui-Chuan Yu(4), Hui‐Ling Chen(3)